Omnicell, Inc. (OMCL - Free Report) was a big mover last session, as its shares rose over 13% on the day. The move came after the company reported robust second-quarter 2017 results. This led to far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $42.25 to $43.80 in the past one month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Omnicell currently carries a Zacks Rank #3 (Hold).
A better-ranked stock in the Medical Info Systems space is Cerner Corporation (CERN - Free Report) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is OMCL going up? Or down? Predict to see what others think: Up or Down
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>